63 related articles for article (PubMed ID: 27264767)
1. Looking for Our Ten Years Results for Coronary Heart Disease and Ischemic Stroke Group for the Standpoint of Haemostasis.
Ulutin T; Sönmez H; Domaniç N; İnce B; Bayram Gürel Ç; Ural D; Vural VA; Harmancı H; Özaydın A; İnce E; Buyru Sayhan N; Yılmaz Ş; Kanıgür G; Kökoğlu E
Turk J Haematol; 2002 Jun; 19(2):255-63. PubMed ID: 27264767
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic markers in ischemic stroke of undetermined etiology.
Ince B; Bayram C; Harmanci H; Ulutin T
Thromb Res; 1999 Nov; 96(3):169-74. PubMed ID: 10588458
[TBL] [Abstract][Full Text] [Related]
3. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
4. Detection of prothrombotic state in ischemic stroke by monitoring plasma molecular markers.
Nagayama M; Shinohara Y; Nagayama T
J Stroke Cerebrovasc Dis; 1994; 4(4):250-4. PubMed ID: 26486246
[TBL] [Abstract][Full Text] [Related]
5. Alterations of platelet, coagulation, and fibrinolysis markers in patients with acute ischemic stroke.
Uchiyama S; Yamazaki M; Hara Y; Iwata M
Semin Thromb Hemost; 1997; 23(6):535-41. PubMed ID: 9469626
[TBL] [Abstract][Full Text] [Related]
6. D-dimers predict stroke subtype when assessed early.
Isenegger J; Meier N; Lämmle B; Alberio L; Fischer U; Nedeltchev K; Gralla J; Kohler HP; Mattle HP; Arnold M
Cerebrovasc Dis; 2010; 29(1):82-6. PubMed ID: 19907168
[TBL] [Abstract][Full Text] [Related]
7. Alterations of haemostatic markers in various subtypes and phases of stroke.
Yamazaki M; Uchiyama S; Maruyama S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
[TBL] [Abstract][Full Text] [Related]
8. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
Oda H; Ohno M; Ohashi H
Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
[TBL] [Abstract][Full Text] [Related]
9. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
10. Study of hemostatic biomarkers in acute ischemic stroke by clinical subtype.
Hirano K; Takashima S; Dougu N; Taguchi Y; Nukui T; Konishi H; Toyoda S; Kitajima I; Tanaka K
J Stroke Cerebrovasc Dis; 2012 Jul; 21(5):404-10. PubMed ID: 22516429
[TBL] [Abstract][Full Text] [Related]
11. Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke.
Haapaniemi E; Soinne L; Syrjälä M; Kaste M; Tatlisumak T
Acta Neurol Scand; 2004 Oct; 110(4):242-7. PubMed ID: 15355488
[TBL] [Abstract][Full Text] [Related]
12. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
Uchida Y
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of intracardiac thrombi by various imaging techniques and activation of platelets and coagulation-fibrinolysis in patients with cardioembolic stroke].
Uchiyama S; Yamazaki M; Iwata M; Maruyama S
Rinsho Shinkeigaku; 1996 Mar; 36(3):429-35. PubMed ID: 8741345
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic markers in acute transient ischemic attacks.
Fon EA; Mackey A; Côté R; Wolfson C; McIlraith DM; Leclerc J; Bourque F
Stroke; 1994 Feb; 25(2):282-6. PubMed ID: 8303732
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
Takahashi H; Wada K; Takizawa S; Sakurai G; Hanano M; Niwano H; Tatewaki W; Shibata A
Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
[TBL] [Abstract][Full Text] [Related]
16. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
Nakajima H
Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte sedimentation rate as a marker of inflammation and ongoing coagulation in stroke and transient ischaemic attack.
Swartz JE; Jacobson BF; Connor MD; Bernstein PL; Fritz VU
S Afr Med J; 2005 Aug; 95(8):607-12. PubMed ID: 16201006
[TBL] [Abstract][Full Text] [Related]
18. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
Oldgren J; Siegbahn A; Grip L; Linder R; Thygesen K; Wallentin L
Thromb Haemost; 2004 Feb; 91(2):381-7. PubMed ID: 14961168
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
